title: Growth factors and other targets for rational application as intervention agents.
authors.affiliation: Biomarkers and Prevention Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: J L
authors.initials: JL
authors.lastname: Mulshine
authors.forename: M
authors.initials: M
authors.lastname: Birrer
authors.forename: A M
authors.initials: AM
authors.lastname: Treston
authors.forename: F
authors.initials: F
authors.lastname: Scott
authors.forename: K
authors.initials: K
authors.lastname: Quinn
authors.forename: I
authors.initials: I
authors.lastname: Avis
authors.forename: F
authors.initials: F
authors.lastname: Cuttitta
mesh_terms: D016588:Anticarcinogenic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D015195:Drug Design; D005260:Female; D019886:Gastrin-Releasing Peptide; D006133:Growth Substances; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D008297:Male; D016609:Neoplasms, Second Primary / Q000517:prevention & control; D009857:Oncogenes; D010455:Peptides / Q000037:antagonists & inhibitors; D012189:Retrospective Studies; D013183:Sputum / Q000166:cytology; D013629:Tamoxifen / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
chemical_list: D016588:Anticarcinogenic Agents; D000970:Antineoplastic Agents; D006133:Growth Substances; D010455:Peptides; D013629:Tamoxifen; D019886:Gastrin-Releasing Peptide; D015474:Isotretinoin